Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
US Army
Argus Health
Boehringer Ingelheim
Cantor Fitzgerald

Generated: October 21, 2017

DrugPatentWatch Database Preview

MAXIPIME Drug Profile

« Back to Dashboard

What is the patent landscape for Maxipime, and when can generic versions of Maxipime launch?

Maxipime is a drug marketed by Hospira Inc and is included in one NDA.

The generic ingredient in MAXIPIME is cefepime hydrochloride. There are twenty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.

Summary for Tradename: MAXIPIME

US Patents:0
Suppliers / Packagers: see list2
Bulk Api Vendors: see list17
Clinical Trials: see list2
Patent Applications: see list3,429
Drug Prices:see details
DailyMed Link:MAXIPIME at DailyMed

Pharmacology for Tradename: MAXIPIME

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
cefepime hydrochloride
INJECTABLE;INJECTION050679-002Jan 18, 1996APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira Inc
cefepime hydrochloride
INJECTABLE;INJECTION050679-003Jan 18, 1996APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira Inc
cefepime hydrochloride
INJECTABLE;INJECTION050679-001Jan 18, 1996APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus